Background-Cardiovascular magnetic resonance has provided important information on the diagnosis and risk stratification of hypertrophic cardiomyopathy (HCM) in adults; however, comparable data are absent for HCM in children. The study was performed to evaluate cardiovascular magnetic resonance characteristics in children with idiopathic HCM. Methods and Results-Cardiovascular magnetic resonance was performed in 71 consecutive children with idiopathic HCM (age, 12.8±4.1 years; 46 boys and 25 girls). The left ventricular (LV) parameters indexed by body surface area were calculated and compared with those in 71 healthy children (age, 13.1±3.3 years; 51 boys and 20 girls). Among those with HCM, concentric LV hypertrophy occurred in 9 patients (12.7%): in 2 children, it progressed into end-stage phase. The prevalence of late gadolinium enhancement (LGE) was 73%, and the extent of LGE was 10.4±8.3% of LV mass. Children with HCM with LGE had greater LV mass indexed (112.7±57.9 versus 70.3±37.4 g/m 2 ; P=0.025) but had no significant difference in maximal LV wall thickness indexed (19.4±6.3 versus 18.1±7.9 mm/m 2 ; P=0.513). In addition, the hazard ratio of adverse events for the extent of LGE was 1.1 (P=0.004). The follow-up (2.4±1.6 years) demonstrated that LGE was associated with adverse events in children with HCM (log-rank; P=0.029). Conclusions-The prevalence and extent of LGE in children with HCM approximate to those in adults with HCM. Furthermore, children with HCM with LGE tend to have adverse events, and larger researches with longer follow-up are required. (Circ Heart Fail. 2013;6:1013-1020.) The online-only Data Supplement is available at http://circheartfailure.ahajournals.org/lookup/suppl/
H ypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a population prevalence of 1 in 500, and the incidence is ≈0.47 per 100 000 in children. 1, 2 Recent researches have shown that HCM accounted for 42% of cardiomyopathy in childhood, and that annual HCM-related mortality was ≈1%. 2, 3 As a genotypically and phenotypically heterogeneous cardiac disease, HCM demonstrates a diverse clinical presentation and course in childhood. Furthermore, HCM is considered as the common cause of sudden cardiac death (SCD) and congestive heart failure in children and young individuals. 1, 4, 5 Until now, however, it is still a challenge to identify high-risk children with HCM.
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Cardiovascular magnetic resonance (CMR) has the potential to detect subtle abnormalities in myocardial anatomy, which makes it superior to the other imaging modalities for the diagnosis of HCM. 6 Furthermore, late gadolinium enhancement (LGE) enables the identification of myocardial fibrosis, which is associated with adverse outcomes. 7, 8 In adult patients, CMR has provided important information on the diagnosis and risk stratification of HCM. [9] [10] [11] However, in children with HCM, the comparable researches are currently lacking. Therefore, we hypothesized that LGE would also be associated with adverse events in HCM in childhood. In this study, we sought to investigate the CMR characteristics in HCM in childhood.
Methods

Study Patients
From January 2006 to January 2012, a total of 71 consecutive children with idiopathic HCM were included in this study (46 boys and 25 girls, <18 years of age at the time of CMR examination). The chidren with HCM with known cause were screened and excluded in the study (n=4): inborn errors of metabolism (n=2), malformation syndrome (n=1), and neuromuscular disorder (n=1). In addition, children with HCM with contraindications to CMR and Gd-DTPA (gadolinium-diethylenetriamine pentaacetic acid) were also excluded, and the renal function of all children was confirmed in the normal limit before CMR examination. In the 71 children with idiopathic HCM, the mean age was 12.8±4.1 years (12.7±4.1 years for boys and 12.9±4.3 years for girls), and the body surface area (BSA) was 1.4±0.3 m 2 (1.4±0.4 m 2 for boys and 1.3±0.3 m 2 for girls). All children underwent the detailed evaluation of CMR, chest x-ray, transthoracic echocardiography (TTE), and 12-lead ECG. In addition, selective coronary angiography was performed in 17 children with hypertrophic obstructive cardiomyopathy (HOCM), and 99m Tc-MIBI SPECT ( 99m Tc-MIBI single photon emission computed tomography) imaging was performed in 4 patients. The study was approved by September 2013 our hospital research ethics committee, and informed consent was obtained from the parents of each child with HCM.
Definitions
HCM in childhood was diagnosed by the presence of hypertrophied left ventricle (LV; wall thickness >2 SD above the normal population mean for BSA) in the absence of another disease that could account for the hypertrophy. 2, 12 Idiopathic HCM was defined as that in patients in whom no specific origin had been established. 2 HOCM was considered to be present when pressure gradient was estimated to be ≥20 mm Hg (left cardiac catheterization) or 30 mm Hg (continuouswave Doppler echocardiography) under basal conditions. 13 LV apical aneurysm was defined as a discrete thin-walled dyskinetic or akinetic segment of the most distal portion of the chamber with a relatively wide communication to the LV cavity. 14 The end-stage phase of HCM was defined as an LV ejection fraction <50% at rest. 5
Reasons for CMR Evaluation in Children With HCM
In 64 children (including 20 children with HCM family history), the initial diagnosis of HCM was made with TTE, and CMR imaging was indicated to provide additional information. In the remaining 7 children with family history, CMR imaging was indicated because the diagnosis of HCM was suspected, but TTE was inconclusive.
Control Subjects
A total of 71 healthy childhood subjects (51 boys and 20 girls; <18 years of age) without evidence of cardiovascular disease were involved in this study and underwent the detailed evaluation of CMR, chest x-ray, TTE, and 12-lead ECG. All healthy children volunteered for the study, and informed consent was obtained from the parents of each child. The mean age was 13.1±3.3 years (13.3±2.9 years for boys and 12.7±4.1 years for girls), and BSA was 1.4±0.3 m 2 (1.5±0.3 m 2 for boys and 1.3±0.3 m 2 for girls).
Cardiovascular Magnetic Resonance
All examinations were performed on a 1.5-Tesla MR scanner (Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany). For the younger children with HCM (n=9; ≤6 years old), an intravenous cannula was placed, and an infusion of one-third saline solution was started. Ketamine was applied for general anesthesia (1 mg/kg at induction followed by an infusion of 3 to 5 mg/kg per hour) in spontaneously breathing children. Concurrently, atropine was administered intravenously (0.01 mg/kg) or intramuscularly (0.02 mg/kg). For the older children with HCM (n=62; >6 years old), the method was identical to that in the adults. 15 In brief, scout images acquired by using half-Fourier acquisition single-shot turbo spin-echo sequence were used to analyze the morphology and structure of the heart. Retrospective electrocardiographic gating cine images were acquired by using a true fast imaging with steady-state precession (TrueFisp) sequence. The LV 2-chamber long-axis view, 4-chamber long-axis view, LV outflow tract view, and LV short-axis views (contiguous short-axis slices from base to apex, no gap) covering the entire LV were obtained. In the younger children with HCM (non-breath-hold), the following parameters were used: field of view (FOV), 250×188 mm; slice thickness, 4.5 mm; matrix, 96×128 mm; repetition time (TR), 2.8 ms; echo time (TE), 1.39 ms; flip angle, 70°; and number of signal averages, 2 to 4. In the older children with HCM (breath-hold), the parameters were identical to those of adults, and the slice thickness was 6 mm.
Fifteen minutes after bolus injection of 0.2 mmol Gd-DTPA (Magnevist, Schering AG, Berlin, Germany) per kilogram body weight, late enhancement T1-weighted images were acquired with a phase-sensitive inversion recovery sequence. The following parameters were used in the younger children with HCM: FOV, 240×198 mm; slice thickness, 5 mm; matrix, 156×256 mm; TR, 9 ms; TE, 3.45 ms; flip angle, 25°; and bandwidth, 130 kHz/PX. The parameters in the older children with HCM were also identical to those of adults: TR, 6.4 ms/TE, 4.2 ms; section thickness, 6 mm; matrix, 156×256 mm; flip angle, 25°; and bandwidth, 130 kHz/PX. LGE was defined as the area of signal enhancement ≥6 SD of the signal of nonenhanced myocardium. The extent of LGE was expressed as the percentage of total LV mass.
The maximal LV wall thickness was taken as the dimension of the greatest magnitude of the LV wall during end diastole. LV end-diastolic and end-systolic volumes, LV ejection fraction, single volume, cardiac output, and LV mass were calculated. Furthermore, all parameters were indexed to BSA. For the calculation of LV mass, the endocardial and epicardial borders of the LV myocardium were manually planimetered on successive short-axis cine images at end diastole. In the LV mass calculation, papillary muscles were excluded carefully. The LV mass was derived by the summation of discs method and multiplying myocardial muscle volume by 1.05 g/cm 3 .
Follow-Up
Follow-up was performed by review of patient clinical records and by telephonic interview. LV function was re-evaluated by TTE, and arrhythmia was followed by 24-hour ambulatory (Holter) electrocardiographic monitoring. Symptoms related to congestive heart failure were followed too. The adverse events included SCD/resuscitated SCD, development or progression of congestive heart failure, sustained/nonsustained ventricular tachycardia, and stroke. The end point was cardiac death (including resuscitated SCD) or heart transplantation. No patient was lost to follow-up.
Statistical Analysis
The data in the study are expressed as mean±SD, percentage, or median. Independent samples t tests or Wilcoxon rank-sum tests were used to test for statistically significant differences between the 2 groups. The Pearson correlation method was used to assess the intraobserver and interobserver reproducibility. The extent of LGE and other traditional clinical risk markers (syncope, extreme LV wall thickness [≥30 mm], LV obstruction, family history of HCM-related The age and cardiothoracic ratio are expressed as mean value±SD, and the duration of symptoms before CMR is expressed as median (range). CMR indicates cardiovascular magnetic resonance; HCM, hypertrophic cardiomyopathy; HOCM, hypertrophic obstructive cardiomyopathy; LV, left ventricular; NYHA, New York Heart Association; and SCD, sudden cardiac death.
SCD, and presence of end-stage HCM [LV ejection fraction <50%])
of adverse events were all tested with univariate analysis by Cox regression. In addition, Kaplan-Meier survival curves were generated, and the difference between 2 groups was compared by log-rank test. The follow-up time was the interval from the date of CMR examination to the time of adverse event or heart transplantation. A 2-sided P<0.05 was considered statistically significant. Statistical software used in this study was SPSS 16.0.
Results
Baseline Characteristics
Before CMR evaluation, the median for duration of symptoms was 2 years (range, 0.5-8 years; from the onset of symptoms in symptomatic children with HCM or the first clinical manifestation of abnormal ECG/TTE in asymptomatic patients). Among the 71 children with HCM (age range, 2-17 years), chest pain/discomfort occurred in 23 children and syncope in 11 children. Systolic murmur presented in 41 patients. There were 15 patients in New York Heart Association functional class I, 34 patients in class II, 19 patients in class III, and 3 patients in class IV. End-stage HCM (age range, 15-16 years) occurred in 3 children, including 2 children with hypertrophic nonobstructive cardiomyopathy with concentric LV hypertrophy and 1 child with HOCM. HCM-related family history was confirmed in 27 children (including 5 children with HCMrelated SCD family history; Table 1 ).
TTE revealed that rest HOCM presented in 33 children (age range, 7-17 years), and obstruction of right ventricular outlet was identified in 2 patients. Chest x-ray showed that the cardiothoracic ratio was 45.4±6.0%, and that pulmonary venous congestion presented in 3 patients. LV hypertrophy and ST-T wave changes occurred in 64 children. In the 17 patients with HOCM undergoing coronary angiography, myocardial bridging was identified in 4 children, and all located in the left 
CMR Characteristics of Children With HCM and Healthy Children
The detailed CMR characteristics of children with HCM and healthy children are listed in Table 2 . Between children with HCM and healthy ones, there was no significant difference in BSA. In the children with HCM, the LV mass indexed was greater in boys than in girls (108.9±62.1 versus 87.4±41.0 g/m 2 ; P=0.028). However, there was no sexual difference in the maximal LV wall thickness indexed (19.7±6.7 versus 17.7±6.2 mm/m 2 ; P=0.587). Furthermore, the LV mass indexed correlated positively with maximal LV wall thickness indexed (r=0.402; P=0.003). In the control healthy children, there were no significant differences in all CMR characteristics between boys and girls. Among children with HCM, 5.6% (n=4) were associated with right ventricular involvement (Movie I in the onlineonly Data Supplement). Concentric LV hypertrophy occurred in 9 patients (12.7%), including 2 children with end-stage HCM. Septal hypertrophy presented in 60 patients, and apical HCM was identified in 2 children. LV apical aneurysm was identified in 3 older children (4.2%; age range, 15-16 years). Fifty-two children with HCM were associated with extreme LV hypertrophy (>6 SD), and the maximal LV wall thickness was ≥30 mm in 19 children. Maximal LV wall thickness measured by CMR was closely related to that measured by echocardiography (24.9±7.7 versus 23.8±7.6 mm; R 2 =0.896; P<0.001), and the average difference was 2.24±1.43 mm. In addition, 29 children with HCM were associated with extreme LV mass (>6 SD).
The CMR characteristics of children with HCM with LGE are listed in Table 3. LGE was identified in 52 children with HCM (33 boys and 19 girls; accounting for 73%), and the age ranged from 4 to 17 years. Confluent LGE presented in 31 (59.6%) children with HCM, and diffuse LGE presented in 21 (40.4%) children. In the 3 children with LV apical aneurysm (age range, 15-17 years), transmural LGE was identified in the LV apex. The extent of LGE was 10.4±8.3% of LV mass, and all LGE occurred in the hypertrophic LV segments (except for the 3 LV apical aneurysms with transmural LGE in the thin-walled apical segment). Intraobserver and interobserver reproducibility was high, and the average difference in LGE extent (%) was 0.97±0.76% and 1.1±0.80%, respectively. The Pearson correlation coefficient was 0.996 and 0.988, respectively (P<0.001 for both). Children with HCM with LGE were older (13.3±3.6 versus 11.4±5.2 years; P=0.027) and greater LV mass indexed (112.7±57.9 versus 70.3±37.4 g/m 2 ; P=0.025), but no significant difference in the maximal LV wall thickness indexed (19.4±6.3 versus 18.1±7.9 mm/m 2 ; P=0.513). Furthermore, the extent of LGE correlated positively with LV mass indexed (r=0.448; P=0.001) and maximal LV wall thickness indexed (r=0.324; P=0.019). Importantly, LGE was identified in all children with HCM with SCD and end-stage phase, including 2 children with resuscitated SCD (Figure 1 ) and 3 children with end-stage HCM (Figure 2 ; Movies II and III in the online-only Data Supplement). In children with HCM with LGE (n=52), children with adverse events showed a higher LGE extent than children without adverse events (12.8±9.1% versus 9.7±8.0%), but this difference did not reach statistical significance (P=0.319). Furthermore, the extent of LGE and the presence of end-stage HCM were associated with adverse events (LGE extent, hazard ratio, 1.1; hazard ratio [95% confidence interval], 1.03-1.18; P=0.004; the presence of endstage HCM, hazard ratio, 7.71; hazard ratio [95% confidence interval], 1.95-30.54; P=0.004). In the healthy children, no LGE was identified.
The CMR characteristics of children with HOCM are also listed in Table 3 . Thirty-three children with HOCM (including 1 midventricular HOCM) had greater LV mass indexed (127.1±60.8 versus 79.1±41.2 g/m 2 ; P=0.003) but had no significant differences in maximal LV wall thickness indexed (20.2±7.4 versus 18.0±5.9 mm/m 2 ; P=0.196) and LGE extent (11.4±9.2% versus 9.2±7.1%; P=0.134).
Follow-Up
The average length of follow-up was 2.4±1.6 years (n=71), and there was no statistically significant difference in the length of follow-up between LGE (n=52) and no-LGE (n=19) group (2.3±1.6 versus 2.7±1.6 years; P=0.499).
In the children with HCM with LGE, adverse events occurred in 11 patients with HCM (Table 4; Figure 3 ). Ventricular fibrillation occurred in 2 children with HCM, who were all resuscitated fortunately. Subsequently, implantable cardioverter-defibrillator was implanted in 1 of the 2 children. Nonsustained ventricular tachycardia was identified in 7 patients. Progression of congestive heart failure occurred in 2 of the 3 children with end-stage HCM. Finally, heart transplantation was performed in the 2 children. However, in the children with HCM without LGE, no adverse event was identified during the follow-up (Kaplan-Meier survival analysis; P=0.029).
Discussion
LGE on CMR has been well characterized in HCM in adulthood, which provided important information on risk stratification. [9] [10] [11] However, until now, there is no comparable report on HCM in childhood. Our findings demonstrated that LGE Figure 1 . A 12-year-old girl with hypertrophic nonobstructive cardiomyopathy (HNCM). Left ventricular hypertrophy was mainly located in the interventricular septum and anterior wall. Diffuse late gadolinium enhancement occurred in the interventricular septum (A, in 4-chamber view; B, in short-axis view). In the follow-up, she was resuscitated from recurrent ventricular fibrillation, and implantable cardioverterdefibrillator was implanted subsequently. also occurs in the children with HCM, and the prevalence and extent of LGE were similar to those in adults with HCM. Furthermore, LGE was associated with adverse events in the children with HCM. In addition, healthy childhood subjects were also imaged for the comparison, and the normal ranges were obtained, which can provide additional information about the normal anatomy of CMR in children.
In this study, the prevalence and extent of LGE in children with HCM approximated to those in adults with HCM. [9] [10] [11] To our knowledge, this is the first systematic report to present pediatric HCM with LGE. Limited by the highly selected cohort, the findings of this study mainly reflected symptomatic children with HCM. Therefore, the prevalence of LGE in common childhood population with HCM required further researches. Children with HCM with LGE are older and have greater LV mass indexed but no significant difference in the maximal LV wall thickness indexed. However, the mechanism was unclear. Recent researches demonstrated that LGE might be determined by multiple factors: microvascular ischemia and microscopic replacement fibrosis because of small intramural coronary arteriole dysplasia, 8, 16 phenotypic expression of increased myocardial connective tissue deposition because of the causative sarcomeric gene mutations, 17 LV mass or wall thickness, and so on. In addition, LGE has been detected in a few patients with preclinical HCM, in whom the LV hypertrophy was lacking. 18, 19 Considering that LGE might progress with time, 20 further researches were required to evaluate the progression of LGE in children with HCM.
Compared with the adults with HCM, LGE was also associated with adverse events in children with HCM. LGE had the tissue characterization for myocardial fibrosis, which might play an important role in the ventricular tachycardia and decreased LV function in HCM. 10, 11 Previous researches have shown that LGE was associated with progressive disease and increased risk for SCD in adults. [9] [10] [11] In addition, patients with HCM with LGE tended to have more markers of risk of SCD than those without LGE. 9 Therefore, LGE is commonly thought to be associated with the adverse outcome in adult patients with HCM. In this study, the extent of LGE was also associated with adverse events, which suggested the prognostic role of LGE in children with HCM. Limited by the small number of children with HCM in this study, larger studies with longer follow-up and more events are required.
In the children with HCM, concentric LV hypertrophy accounted for 12.7%, and the prevalence was higher than that of adults with HCM. 21 Furthermore, concentric hypertrophy without LV obstruction was identified in 2 children with end-stage HCM and was confirmed by subsequent heart transplantation. These findings suggested that children with HCM with concentric LV hypertrophy might be in the risk of progressing into congestive heart failure; however, the mechanism remained unclear. Previous researches demonstrated that the patients who developed end-stage HCM had increased LV hypertrophy not confined to the interventricular septum. 5 It was conceived that a widespread distribution of LV hypertrophy might exacerbate myocardial ischemia and eventually lead to end-stage HCM. 5 In addition, the patients with end-stage HCM were usually diagnosed at an earlier age and pediatric patients accounted for approximately one third. 22 Therefore, it was important to identify the pediatric concentric HCM, which contributed to early treatment considerations. LV apical aneurysm was identified in 3 children with HCM. In addition, transmural LGE was identified in the LV apical segments of these children. LV apical aneurysm in HCM was a rare but distinctive subset, and the detailed mechanism was still unknown. 14 Previous researches have shown that LV apical aneurysms occurred mainly in midventricular HOCM or apical HCM and were usually associated with the risk of adverse clinical events (the annual event rate was ≈11%). 14, 23 Therefore, it was clinically important to detect LV apical aneurysms in patients with HCM, which should raise novel treatment considerations. Interestingly, in this study, all LV apical aneurysms occurred in the older children. We speculated that the LV apical aneurysms might develop slowly over time.
There were 3 children with end-stage HCM in this study, and the prevalence was similar to that of adults with HCM (≈4.9%-5.4%). 5 In contrast, SCD occurred only in 2 children, who were all resuscitated after ventricular fibrillation. Therefore, our findings agreed with the previous research that the end-stage HCM occurred at least as common as SCD in children with HCM. 4 Importantly, LGE was identified in all children with HCM with end-stage phase and SCD, which further suggested the prognostic value of LGE in predicting adverse events in children with HCM. Further researches are required to evaluate the long-term outcomes in a large cohort.
Study Limitations
This study was based on a highly selected group of mainly symptomatic children with HCM, which did not reflect the broad spectrum of HCM in childhood. Another limitation was that the number of actual adverse events was small in this study. Therefore, larger studies with longer follow-up and more events are required. In addition, coronary angiography was performed only in 24% of children with HCM, and it was unclear about the coronary arteries in other children with HCM.
Conclusions
The prevalence and extent of LGE in HCM in childhood are similar to those in HCM in adulthood, and the extent of LGE is an independent predictor of adverse events. Children with HCM with LGE tend to have adverse outcome, and further researches with longer follow-up are required to evaluate the progression of HCM in childhood.
